fda warning letters compounded semaglutide september 2025 U.S. sends drug advertising to Lilly, Novo, Hims FDA warns against compounded GLP-1

Simultaneous fat loss may be occurring, but water weight masks it on the scale

Louis DeGironemo , tailors every weight loss plan to your unique needs and lifestyle goals

Covered workers in firms with a relatively large share of older workers (where at least 35% are age 50 or higher) have a lower average percent contribution for family coverage than those in firms with a smaller share of older workers (24% vs

First review of the potential renoprotective effects and mechanisms of GLP-1R agonists and DPP-4 inhibitors in preclinical studies and in early clinical studies involving patients with diabetes

This content is provided for scientific and educational purposes only and does not constitute medical advice, treatment recommendations, or clinical guidance